The substantial complexity and vast dynamic range of protein abundance in biological fluids, notably serum and plasma, present a formidable challenge for comprehensive protein analysis. Integration of multiple technologies is required to achieve highresolution and high-sensitivity proteomics analysis of biological fluids. We have implemented an orthogonal three-dimensional intact-protein analysis system (IPAS), 
Introduction
Comprehensive profiling of the serum and plasma proteomes has substantial relevance to the identification of circulating protein biomarkers that may have predictive value and utility for disease diagnosis and management. As an orthogonal separation technique, two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) [1] [2] [3] is seminal to the field of proteomics, especially with respect to its parallel quantitative display of proteins. abundance proteins in such complex protein mixtures as the plasma proteome. Hence, many alternative strategies have been explored [4] [5] [6] [7] . For example, a shotgun technique designated MuDPIT (multidimensional protein identification technology) coupled to an orthogonal two-dimensional HPLC system consisting of cation exchange and reverse phase (RP) chromatography with ESI MSMS for peptide analysis has been developed 8, 9 .
However, analysis of random peptides from complex digests may not be sensitive to protein post-translational modifications and other types of protein processing and may therefore miss many relevant protein isoforms associated with disease states.
The dynamic range of plasma protein abundance spans at least twelve orders of magnitude. Proteomic analysis of sufficient sample to detect low abundance proteins invariably means excessive loading of albumin and several other high-abundance proteins that comprise greater than 90% of the total protein mass of plasma. Excessive loading of the high abundance proteins may interfere with the analysis of lower abundance proteins 10 . We have combined immunodepletion of abundant plasma proteins and protein labeling with Cy dyes, with an orthogonal, three-dimensional (3-D) intact-protein analysis system (IPAS) to quantitatively profile the human plasma proteome for disease related changes, using paired samples. This quantitative analysis system separates mixtures of proteins labeled with Cy dyes in the 1 st dimension according to charge, in the 2 nd dimension according to hydrophobicity, and in the 3 rd dimension according to molecular mass, followed by mass spectrometric analysis of proteins of interest. We have applied IPAS to the profiling of the human plasma proteome to determine feasibility of detecting and identifying protein changes that occur in acute graft-versus-host-disease (GVHD), a major complication of allogeneic bone marrow transplantation. A much wider range of protein changes was uncovered using IPAS compared to 2-D PAGE.
Results

Quantitative Protein Differences Between Pre-and Post-GVHD Samples
A total of 194 protein bands exhibited a 2.0-fold or greater quantitative difference between the pre-GVHD and post-GVHD pooled samples. Some of the bands migrated to the same position in the third dimension from contiguous second dimension fractions likely representing the same proteins that were collected into two or more fractions.
However, 85 bands were considered to represent distinct protein forms based on their occurrence in non-neighboring fractions in the first or second dimension separations or based on their occurrence as distinct MW bands in the third dimension separation.
Protein was digested from corresponding gel pieces and analyzed by nanoflow HPLC ESI Q-TOF mass spectrometry, yielding 48 distinct protein identifications with two or more peptides, based on protein sequence database analysis (Table 1a ,b). Some of the protein bands that yielded identifications by mass spectrometry yielded more than one protein identification, with a frequency of 5% for dual identifications from the same band. We have observed that when two proteins were identified in a digest from a band, frequently one of the two proteins also occurred in a neighboring band, with the two bands occurring in too close proximity to be cleanly cut out by the spot picker.
The abundance in human plasma of the identified proteins was evaluated (Table 1) to assess the sensitivity and the dynamic range of IPAS. Some of the proteins that have been detected are relatively abundant proteins whose levels range from 10 -3 -10 -6 M.
These proteins include Serum amyloid A and P, Apolipoproteins A-I/IV/C-III and Complement C3/C4. Such proteins usually occurred in more than one fraction. Other proteins such as B-lymphocyte surface antigen, Leukocyte antigen CD97, T cell receptor beta were generally found in far less abundance. These proteins usually occurred in fewer fractions than the relatively more abundant proteins and some occurred as a single band from a single fraction.
To assess the extent to which protein differences observed between pre-and post-GVHD pools are reflected in differences in paired, non-pooled pre-and post-GVHD samples from individual patients, plasma from four additional individual patients were examined ( Figure 2 ). We singled out nine protein bands that exhibited quantitative differences between pre-and post-GVHD pools for which identifications were obtained by mass spectrometry for their identification and quantitative analysis in non-pooled samples. We found concordant quantitative changes and identity between the pooled and the nonpooled samples ( Figure 2 , Table 2 ). MS/MS data from the pooled sample were corroborated by mass spectrometry of corresponding protein bands in the individual samples yielding the same protein identity. Through this approach we were able to confirm several of the potentially immunologically relevant proteins detected in the pooled sample in one or more of the individual samples, including T cell receptor beta, vitronectin, integrin alpha-L and proline-rich protein 4.
Detection of Protein Isoforms by IPAS
In some cases, among the identified proteins that exhibited quantitative changes with GVHD, the same proteins occurred in different positions in the 3-D separations, indicative of differences in molecular weight and/or pI, suggestive of their occurrence as isoforms (Table 1a ,b). Some of the differences between isoforms may represent chemical post-translational modifications. Others may represent cleavages, given the differences in observed molecular masses. Frequently one isoform exhibited up-regulation whereas another isoform exhibited down-regulation, as shown for apolipoprotein A-I ( Figure 3) and complement C3 (Figure 4 ), proteins that are affected by GVHD 16 and also known to exhibit cleavage in part as a result of the systemic inflammation that occurs during acute GVHD 17, 18 .
Effect of Immunodepletion of Abundant Proteins
To test the efficacy of the immunodepletion procedure, both the flow-through and the fractions bound to the immunodepletion column ( Figure Only four such protein spots were detected by 2-D PAGE. The two neighboring spots located in the lower part of the 2-D gel in figure 6 were identified by MSMS analysis as Complement C3 whose plasma levels were known to be increased in GVHD 16 . This is in contrast to the detection of 194 protein bands with a 2.0-fold or greater change in GVHD by IPAS.
Discussion
We have implemented a system to separate intact proteins in three dimensions, and have examined the feasibility of this system to quantitatively profile the human plasma proteome before and after the onset of GVHD, leading to the identification of a large number of proteins that are affected by GVHD. We have compared the resolution achieved with this system relative to 2-D gels. Various schemes have been previously implemented for sample preparation prior to 2-D gel analysis to improve the yield of low abundance proteins. We have compared the yield of protein differences related to GVHD with the three dimensional system relative to differential in-gel electrophoresis (DIGE)
involving tagging pairs of samples with different fluorescent dyes (Cy3 and Cy5) 19 so that the sample preparation in this comparison is identical. Thus, using aliquots of the same samples for both DIGE and the three dimensional system, we have demonstrated increased resolution of the three dimensional system and increased sensitivity compared to 2-D gel analysis of the same tagged, paired samples.
It is clear that a greater number of proteins exhibited quantitative differences than the number of proteins that were identified. The extent of protein identification is related to the sensitivity of the methods utilized for protein identification. As such methods increase in sensitivity it is likely that additional proteins that occur at low abundance and that are detected using IPAS will be identified using mass spectrometry. Of interest is the fact that several low abundance proteins that exhibited quantitative changes by IPAS yielded identification by LC-MSMS based on single peptides. Therefore their identification was not considered to be definitive. These include interleukin-22, tumor necrosis factor, and hepatocyte growth factor (HGF) [11] [12] [13] [14] [15] whose abundance is among some of the lowest for plasma proteins (<10 -12 M). Tumor necrosis factor is known to be an important mediator of tissue damage in GVHD and its role in alloreactive responses has been demonstrated [11] [12] [13] . Interestingly, in an independent study based on immunoassays, an approximate 6-fold increase (from 555+42 pg/ml to 3098+967 pg/ml) in the level of HGF with GVHD, was reported 14 . IL-22 is secreted by T cells and induces the production of acute-phase reactants in vitro and in vivo, suggesting its involvement in inflammation 15 . Additional validation studies are needed to confirm the identity and quantitative changes in proteins identified based on single peptides.
We have identified in our study proteins that were previously known to be affected by GVHD as well as novel proteins not previously known to be affected by this disorder.
Acute GVHD remains the major toxicity of allogeneic BMT. There is no definitive laboratory test that distinguishes GVHD from other toxicities and BMT complications such as veno-occlusive disease. Severe GVHD has an extremely poor prognosis 17 . Thus the discovery of proteins in serum or plasma that are potential biomarkers for GVHD may lead to the development of a diagnostic test that is sensitive and specific for this disorder. The identification of 48 proteins that changed in their abundance with GVHD represents a first step toward such a test.
It should be noted that the identified protein bands that exhibited quantitative differences between the pre-and post-GVHD samples may represent particular isoforms of the proteins to which they are related or from which they are derived. Other isoforms may occur in plasma that were unaffected by GVHD. Thus, it is likely that some of the changes in plasma proteins associated with GVHD may be isoform specific as we have observed for some of the proteins including apoA1.
The ability to keep proteins intact during sample preparation and separation has important advantages compared with strategies that digest proteins at an earlier step. These advantages include the ability to quantify and recover proteins as well as to assess posttranslational modifications and cleavage. Given the improved resolution achieved with the addition of a third dimension of separation of intact proteins, it would be reasonable to consider various alternatives in each of the three separation modes. For example, ion exchange based separation may be substituted for ampholyte based isoelectric focusing in the first dimension and size based separation in the third dimension may be accomplished by capillary electrophoresis using polymers as a molecular sieve matrix that allows proteins to be resolved based on molecular mass [20] [21] [22] . Capillary electrophoresis in the third dimension separation could be multiplexed to increase throughput and would facilitate protein recovery by eliminating the need for gel cutting and protein extraction from gels [23] [24] [25] . Automation of the separation system can also be envisaged. Cy3 (after disease), as described below.
Material and Methods
Plasma Sample Preparation
Pre-fractionation Immunodepletion Chromatography
The six most abundant plasma proteins (albumin, IgG, IgA, transferrin, haptoglobin and α-1-antitrypsin) consisting roughly of 90% of the total protein in the pooled aliquots were removed by immunodepletion chromatography (Multiple Affinity Removal Column HU-6, 4.6mm ID x 100mm; Agilent, Wilmington, DE). Two columns, in tandem, were used to increase the loading capacity to 75 µl of plasma (~4.6 mg plasma protein) per run. The dual-pump HPLC system was installed in-house, with the UV detector wavelength set at 280 nm.
The immunodepletion columns were equilibrated in Buffer A (Agilent) for 10 min at a flow rate of 0.5 ml/min. 75 µl of plasma was diluted 5-fold in Buffer A, then injected onto the immunodepletion column. The flow-through fractions were collected and stored at -80 o C until use. Bound proteins were eluted from the column in Buffer B at a flow rate of 0.5 ml/min (Agilent), after which the column was re-equilibrated in Buffer A. 
Concentration and Cy-dye Labeling of Plasma Proteins
Protein Separations
The workflow of 3-D separations is shown in Figure 1 . Protein Visualization and Image Analysis Gels were scanned directly using a 9200
Typhoon Scanner. Protein expression was quantitatively analyzed with the DeCyder Software Package (DeCyder version 3.5, Amersham). Thresholds for assigning differential expression between the two pools were set at a minimum 1.5-fold change.
Gel pieces from selected bands were excised for MS analysis using the Ettan Spot Picker (Amersham). Precursor-ion mass accuracy: 0.1Da; fragment-ion mass accuracy: 0.1Da; no modification; 1 missed cleavage; trypsin was used as the proteolytic enzyme.
MS Analysis
Smoothing was applied using the Savitzky Golay mode, with the smooth window (channels) set at ±3 and a smooth number of 2; The minimum peak width at half height (channel) was set at 4, with a centroid top of 80%; charge states were calculated and peaks de-isotoped. Table 2 -Concordance of fold change among individual and pooled patient's sera for some biologically relevant proteins. The P Value is from a two-sided T-test of no change, based on log-transformed data.
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